- Home
- ELTX vs DBI Comparison
ELTX vs DBI Comparison
Compare ELTX & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTX
- DBI
- Stock Information
- Founded
- ELTX 2011
- DBI 1991
- Country
- ELTX United States
- DBI United States
- Employees
- ELTX N/A
- DBI N/A
- Industry
- ELTX Biotechnology: Pharmaceutical Preparations
- DBI Clothing/Shoe/Accessory Stores
- Sector
- ELTX Health Care
- DBI Consumer Discretionary
- Exchange
- ELTX Nasdaq
- DBI Nasdaq
- Market Cap
- ELTX 158.5M
- DBI 138.7M
- IPO Year
- ELTX N/A
- DBI 1991
- Fundamental
- Price
- ELTX $9.15
- DBI $4.39
- Analyst Decision
- ELTX Strong Buy
- DBI Hold
- Analyst Count
- ELTX 1
- DBI 2
- Target Price
- ELTX $13.00
- DBI $4.50
- AVG Volume (30 Days)
- ELTX 110.4K
- DBI 647.6K
- Earning Date
- ELTX 11-13-2025
- DBI 12-09-2025
- Dividend Yield
- ELTX N/A
- DBI 4.59%
- EPS Growth
- ELTX N/A
- DBI N/A
- EPS
- ELTX N/A
- DBI N/A
- Revenue
- ELTX N/A
- DBI $2,917,437,000.00
- Revenue This Year
- ELTX N/A
- DBI N/A
- Revenue Next Year
- ELTX N/A
- DBI $2.53
- P/E Ratio
- ELTX N/A
- DBI N/A
- Revenue Growth
- ELTX N/A
- DBI N/A
- 52 Week Low
- ELTX $4.60
- DBI $2.18
- 52 Week High
- ELTX $12.62
- DBI $6.29
- Technical
- Relative Strength Index (RSI)
- ELTX 51.67
- DBI 65.60
- Support Level
- ELTX $7.87
- DBI $3.29
- Resistance Level
- ELTX $8.99
- DBI $4.11
- Average True Range (ATR)
- ELTX 0.53
- DBI 0.26
- MACD
- ELTX 0.08
- DBI 0.04
- Stochastic Oscillator
- ELTX 82.72
- DBI 96.85
About ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.